[go: up one dir, main page]

DE60217710D1 - Neue formulierung - Google Patents

Neue formulierung

Info

Publication number
DE60217710D1
DE60217710D1 DE60217710T DE60217710T DE60217710D1 DE 60217710 D1 DE60217710 D1 DE 60217710D1 DE 60217710 T DE60217710 T DE 60217710T DE 60217710 T DE60217710 T DE 60217710T DE 60217710 D1 DE60217710 D1 DE 60217710D1
Authority
DE
Germany
Prior art keywords
new formulation
formulation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60217710T
Other languages
English (en)
Other versions
DE60217710T2 (de
Inventor
Gillian Eccleston
Ronald Paterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE60217710D1 publication Critical patent/DE60217710D1/de
Application granted granted Critical
Publication of DE60217710T2 publication Critical patent/DE60217710T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60217710T 2001-10-30 2002-10-29 Neue formulierung Expired - Fee Related DE60217710T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0103613A SE0103613D0 (sv) 2001-10-30 2001-10-30 Novel formulation
SE0103613 2001-10-30
PCT/SE2002/001956 WO2003037299A1 (en) 2001-10-30 2002-10-29 Novel formulation

Publications (2)

Publication Number Publication Date
DE60217710D1 true DE60217710D1 (de) 2007-03-08
DE60217710T2 DE60217710T2 (de) 2007-11-15

Family

ID=20285820

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217710T Expired - Fee Related DE60217710T2 (de) 2001-10-30 2002-10-29 Neue formulierung

Country Status (7)

Country Link
US (1) US20050037081A1 (de)
EP (1) EP1450762B1 (de)
JP (1) JP2005507408A (de)
DE (1) DE60217710T2 (de)
ES (1) ES2278978T3 (de)
SE (1) SE0103613D0 (de)
WO (1) WO2003037299A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678817B2 (en) 2005-06-03 2010-03-16 Medrx Co., Ltd. Enteric medicinal composition for oral use
EP2938347A4 (de) * 2012-12-30 2016-08-10 Hadasit Med Res Service Verwendung von alginatzusammensetzungen zur verhütung oder verminderung von leberschäden durch hepatotoxika
EP3302445A1 (de) * 2015-06-03 2018-04-11 Ewos Innovation AS Orales freisetzungssystem für bioaktive wirkstoffe
EP3968980A1 (de) 2019-05-14 2022-03-23 Clexio Biosciences Ltd. Behandlung von nächtlichen symptomen und morgendlicher akinesie bei personen mit morbus parkinson
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766124A (en) * 1954-05-25 1956-10-09 American Cyanamid Co Antibiotic-containing ice composition
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US5034378A (en) * 1988-12-15 1991-07-23 James P. Cox Synergistic flavor enhancement nutritional compositions and methods
GB9514438D0 (en) * 1995-07-14 1995-09-13 Danisco Stabilisation process and an enzyme for use in such a process
US5721003A (en) * 1996-03-18 1998-02-24 Kraft Foods, Inc. Foaming coffee creamer and instant hot cappuccino
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6887508B2 (en) * 2002-02-20 2005-05-03 Solae, Llc Protein stabilizing agent

Also Published As

Publication number Publication date
EP1450762B1 (de) 2007-01-17
SE0103613D0 (sv) 2001-10-30
EP1450762A1 (de) 2004-09-01
JP2005507408A (ja) 2005-03-17
US20050037081A1 (en) 2005-02-17
DE60217710T2 (de) 2007-11-15
WO2003037299A1 (en) 2003-05-08
ES2278978T3 (es) 2007-08-16

Similar Documents

Publication Publication Date Title
IS6915A (is) Lyfjablanda
DE60215618D1 (de) Zerstäuber
ATE372174T1 (de) Spritzvorrichtung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE50202178D1 (de) Neue sulfonat-substituierte pyrazolopyridinderivate
BR0210619A (pt) composição
IS7081A (is) Lyfjablanda
ATE335486T1 (de) Hydrazono-malonitrile
DE60105834D1 (de) Spritzvorrichtung
PT1429610E (pt) Composicao herbicida
EP1572867A4 (de) Endothelzellexpressionsmuster
ATE355059T1 (de) Isoxazolopyridinone
ATA18372001A (de) Gelenksbolzenbaueinheit
DE10295005D2 (de) Sprühvorrichtung
ATE319694T1 (de) Phenylalkyne
DE60217710D1 (de) Neue formulierung
ITTO20020747A0 (it) Composizione
DE60206043D1 (de) Neue indolderivate
ATA13992002A (de) Schlackengranulierungsanlage
FI20010970L (fi) Nestekoostumus
FI20012452A0 (fi) Hitsausvirtasuutinmateriaali
ITTO20020745A0 (it) Composizione
EP1459628A4 (de) Herbizidzusammensetzung
DE10295006D2 (de) Bauwerksabdichtung
DK1302107T3 (da) Spröjteapparat

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: ECCLESTON, GILLIAN, GLASGOW, CENTRAL SCOTLAND , GB

Inventor name: PATERSON, RONALD, LOUGHBOROUGH, LEICESTERSHIRE, GB

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee